1Minagawa Y,Kigawaj,IrieT,et al.Radical surgery following neoadjuvant chemotherapy for patients with stage ⅢB cervical cancer[J].Ann Surg Oncol,1998,5(6):539～543
2Frei E.Clinical cancer reseach:an embattled species[J].Cancer,1982,50(9):1979～1992
3Hwang YY,Moop H,Cho SH,et al.Ten-year survival of Patients with locally advanced stage Ⅰb-Ⅱb cervical canter after neoadjuvant chemotherapy and redical hysterectomy[J].Gyancol Oncol,2001,82(1):88～93
5Burnelt AF,Roman LD,CariaAA,et al.A Phase Ⅱ study of gemcitabine and cisplatin in patienfs with advanced, persistent,or recurrent squamous cell carcinoma of the cervix[J]. Gynecol Oncol,2000,76(1):63～66
6Vallejo CT,Machiavelli MR,Perez JE,et al.Docetaxel as neoadjuvant chemotherapy in patients with advanced cervical carcinoma[J].AM J clin Oncol,2003,26(5):477～482
二级参考文献13
1Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin,1999,49:33-64.
2Minagawa Y, Kigawa J, Irie T, et al. Radical surgery following neoadjuvant chemotherapy for patients with stage ⅢB cervical cancer.Ann Surg Oncol,1998,5:539-543.
3Ivanov S, Zervudis S, Ivanov S. Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage Ⅰ B and Ⅱ A cervical cancer.Akush Ginekol (Sofiia),2003,42:22-24.
4Toita T, Mitsuhashi N, Teshima T, et al.Postoperative radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan.Jpn J Clin Oncol,2004,34:99-103.
5Frei E 3rd. Clinical cancer research: an embattled species. Cancer,1982, 50:1979-1992.
6Hwang YY, Moon H, Cho SH, et al. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol,2001, 82:88-93.
7Aoki Y, Sasaki M, Watanabe M, et al. High-risk group in node-positive patients with stage ⅠB, ⅡA, and ⅡB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol,2000, 77:305-309.
8Yamada T, Ohsugi F, Irie T,et al. Extended intraarterial cisplatin infusion for treatment of gynecologic cancer after alteration of intrapelvic blood flow and implantation of a vascular access device. Cardiovasc Intervent Radiol,1996,19:139-145.
9Aoki Y, Tomita M, Sato T, et al. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix. Gynecol Oncol,2001,83:263-267.
10Adachi S, Ogasawara T, Tsubamoto H, et al. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer. Int J Clin Pharmacol Res, 2001,21:105-110.
